These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3453349)

  • 1. Treatment of paucibacillary leprosy by WHO regimen.
    Dey SK; Chanda M; Chowdhury A; Panja SK
    Indian J Dermatol; 1987 Jan; 32(1):11-3. PubMed ID: 3453349
    [No Abstract]   [Full Text] [Related]  

  • 2. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Supervised bimonthly quadruple chemotherapy in 72 paucibacillary leprosy patients in French Guyana].
    Jamet P; Robin Y
    Acta Leprol; 1988; 6(1):35-44. PubMed ID: 3051853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients.
    Katoch K; Ramu G; Ramanathan U; Desikan KV
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):1-8. PubMed ID: 3559333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary appraisal of a WHO-recommended multiple drug regimen in paucibacillary leprosy patients in Malawi.
    Boerrigter G; Ponnighaus JM; Fine PE
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):408-17. PubMed ID: 3418206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug therapy for paucibacillary leprosy: WHO regimen inadequate?
    Pavithran K
    Lepr Rev; 1987 Sep; 58(3):306-8. PubMed ID: 3669872
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 8. Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
    Katoch K; Ramanathan U; Natrajan M; Bagga AK; Bhatia AS; Saxena RK; Ramu G
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):458-64. PubMed ID: 2746075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug therapy for treatment of paucibacillary leprosy in western Kenya--preliminary communications.
    Orege PA; Obura M; Okelo C; Okuku P; Makokha S; Nyawalo J
    East Afr Med J; 1990 Sep; 67(9):632-9. PubMed ID: 2253572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Malta project (a program for the eradication of leprosy)].
    Freerksen E; Rosenfeld M; Despasquale G; Bonnici E
    Acta Leprol; 1988; 6(5):7-46. PubMed ID: 3078224
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidrug therapy in paucibacillary leprosy--a five year experience.
    Grugni A; Nadkarni NJ; Kini MS
    Indian J Lepr; 1988 Oct; 60(4):589-92. PubMed ID: 3253339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paucibacillary multidrug therapy in leprosy. 7 1/2 years experience.
    Kaur S; Sharma VK; Basak P; Kaur I
    Indian J Lepr; 1992; 64(2):153-61. PubMed ID: 1607713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of paucibacillary leprosy with a regimen containing rifampicin, dapsone and prothionamide.
    Katoch K; Natarajan M; Bhatia AS; Yadav VS
    Indian J Lepr; 1992; 64(3):303-12. PubMed ID: 1431319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
    Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 18. Short term WHO advised multiple drug treatment of paucibacillary patients.
    Naafs B; Lyons NF; Matemera BO; Ellis BP
    Indian J Lepr; 1986; 58(2):348-53. PubMed ID: 3805802
    [No Abstract]   [Full Text] [Related]  

  • 19. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
    Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
    Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.